ALIPZA Trademark

Trademark Overview

On Tuesday, March 3, 2020, a trademark application was filed for ALIPZA with the United States Patent and Trademark Office. The USPTO has given the ALIPZA trademark a serial number of 79283663. The federal status of this trademark filing is REGISTERED as of Tuesday, April 13, 2021. This trademark is owned by KOWA COMPANY, LTD. The ALIPZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions and diseases of the circulatory system
alipza

General Information

Serial Number79283663
Word MarkALIPZA
Filing DateTuesday, March 3, 2020
Status700 - REGISTERED
Status DateTuesday, April 13, 2021
Registration Number6317772
Registration DateTuesday, April 13, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of conditions and diseases of the circulatory system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOWA COMPANY, LTD
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressJP
Party NameKOWA COMPANY, LTD
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressJP
Party NameKOWA COMPANY, LTD
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJP

Trademark Events

Event DateEvent Description
Sunday, April 9, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 22, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 25, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 29, 2021GENERIC MADRID TRANSACTION SENT TO IB
Thursday, July 29, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, July 13, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 13, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Saturday, January 23, 2021NOTIFICATION PROCESSED BY IB
Wednesday, January 6, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 6, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 18, 2020EXAMINER'S AMENDMENT ENTERED
Friday, December 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 18, 2020EXAMINERS AMENDMENT E-MAILED
Friday, December 18, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, December 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 17, 2020REFUSAL PROCESSED BY IB
Monday, June 29, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 29, 2020REFUSAL PROCESSED BY MPU
Wednesday, May 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 26, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 20, 2020ASSIGNED TO EXAMINER
Tuesday, April 28, 2020APPLICATION FILING RECEIPT MAILED
Thursday, April 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 22, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 16, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

alipza circulatory system diseases conditions preparations treatment pharmaceutical